International Journal of Health and Pharmaceutical (IJHP)
Vol. 6 No. 2 (2026): May 2026

Analytical Study of Antipsychotic Use in Schizophrenia Patients

Sinta wahyuni (Department Farmasi Klinik,Fakultas Farmasi, Universitas Airlangga, Surabaya, Indonesia)
Yulistiani (Department Farmasi Klinik,Fakultas Farmasi, Universitas Airlangga, Surabaya, Indonesia.)
Indra Zeth (Department Farmasi Klinik)
Josephine P (Department Farmasi Klinik,Fakultas Farmasi, Universitas Airlangga, Surabaya, Indonesia)



Article Info

Publish Date
15 Jun 2026

Abstract

Background: Schizophrenia is a chronic mental disorder that affects thought processes, emotions, perceptions, and behavior. Antipsychotics are divided into first-generation (FGA) and second-generation (SGA) as the main therapy. Objective: To analyze the profile of antipsychotic use in hospitalized schizophrenia patients, including type, dose, route, frequency, and combination patterns. Methods: A retrospective observational study at Menur Mental Hospital Surabaya from July to September 2023 on 66 hospitalized schizophrenia patients. Data were analyzed descriptively. Results: The use of SGAs was more dominant than FGAs. The most common SGAs were clozapine 25 mg and risperidone 3 mg oral. The most common FGAs were trifluoperazine 5 mg and chlorpromazine 100 mg oral. The most common combination pattern was risperidone + clozapine. Conclusion: The pattern of antipsychotic use was dominated by the combination of risperidone and clozapine, reflecting the complexity of schizophrenia management that requires an individual approach.

Copyrights © 2026






Journal Info

Abbrev

IJHP

Publisher

Subject

Nursing Public Health

Description

International Journal of Health and Pharmaceutical (IJHP) e- ISSN : 2808-845X is a communication media and scientific publication in the health and pharmaceutical fields published by Inara Publisher. International Journal of Health and Pharmaceutical (IJHP) contains articles from research focusing ...